JPH07507565A - 非イオン性表面活性剤を含有する医薬組成物 - Google Patents

非イオン性表面活性剤を含有する医薬組成物

Info

Publication number
JPH07507565A
JPH07507565A JP6509047A JP50904793A JPH07507565A JP H07507565 A JPH07507565 A JP H07507565A JP 6509047 A JP6509047 A JP 6509047A JP 50904793 A JP50904793 A JP 50904793A JP H07507565 A JPH07507565 A JP H07507565A
Authority
JP
Japan
Prior art keywords
active substance
ethoxylated
polyoxyethylene
nonionic surfactant
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6509047A
Other languages
English (en)
Japanese (ja)
Inventor
カラトロ,ウィリアム ジェイ.
ガムコースキー,マイケル ジェイ.
ロー,ジュリアン ビー.
Original Assignee
ファイザー・インク.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファイザー・インク. filed Critical ファイザー・インク.
Publication of JPH07507565A publication Critical patent/JPH07507565A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6509047A 1992-10-02 1993-09-02 非イオン性表面活性剤を含有する医薬組成物 Pending JPH07507565A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95596292A 1992-10-02 1992-10-02
US955,962 1992-10-02
PCT/US1993/008107 WO1994007472A1 (en) 1992-10-02 1993-09-02 Pharmaceutical compositions containing nonionic surfactants

Publications (1)

Publication Number Publication Date
JPH07507565A true JPH07507565A (ja) 1995-08-24

Family

ID=25497602

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6509047A Pending JPH07507565A (ja) 1992-10-02 1993-09-02 非イオン性表面活性剤を含有する医薬組成物

Country Status (12)

Country Link
EP (1) EP0662826A1 (fi)
JP (1) JPH07507565A (fi)
KR (1) KR950703333A (fi)
AU (1) AU5095393A (fi)
CA (1) CA2145763A1 (fi)
FI (1) FI934317A (fi)
HU (1) HUT69400A (fi)
IL (1) IL107084A0 (fi)
MX (1) MX9306125A (fi)
TW (1) TW253838B (fi)
WO (1) WO1994007472A1 (fi)
ZA (1) ZA937268B (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008015959A1 (fr) * 2006-08-01 2008-02-07 Otsuka Pharmaceutical Co., Ltd. Composition pharmaceutique permettant une meilleure absorption d'une substance pharmacologiquement active

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1808897A (en) * 1995-12-13 1997-07-03 Dullatur Limited A calcitonin preparation
SE9602145D0 (sv) * 1996-05-31 1996-05-31 Astra Ab New improved formulation for treatment of thromboembolism

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS6233128A (ja) * 1985-08-07 1987-02-13 Toray Ind Inc インタ−フエロン腸溶性経口用製剤
DE68909135T2 (de) * 1988-07-21 1994-04-07 Hoffmann La Roche Insulinzubereitung.
AU1256692A (en) * 1991-02-06 1992-09-07 Schering Corporation Combination of an angiotensin II antagonist or renin inhibitor with a neutral endopeptidase inhibitor
HUT69785A (en) * 1991-12-18 1995-09-28 Pfizer Soybean protein or hydrolylates in pharmaceutical compositions to protect bioaltive peptides from enzymatic inactivation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008015959A1 (fr) * 2006-08-01 2008-02-07 Otsuka Pharmaceutical Co., Ltd. Composition pharmaceutique permettant une meilleure absorption d'une substance pharmacologiquement active
JPWO2008015959A1 (ja) * 2006-08-01 2009-12-24 大塚製薬株式会社 薬理活性物質の吸収性が改善された医薬組成物
JP5300477B2 (ja) * 2006-08-01 2013-09-25 大塚製薬株式会社 薬理活性物質の吸収性が改善された医薬組成物

Also Published As

Publication number Publication date
FI934317A (fi) 1994-04-03
WO1994007472A1 (en) 1994-04-14
ZA937268B (en) 1995-03-30
HUT69400A (en) 1995-09-28
TW253838B (fi) 1995-08-11
EP0662826A1 (en) 1995-07-19
CA2145763A1 (en) 1994-04-14
MX9306125A (es) 1994-04-29
AU5095393A (en) 1994-04-26
FI934317A0 (fi) 1993-10-01
HU9302774D0 (en) 1993-12-28
IL107084A0 (en) 1993-12-28
KR950703333A (ko) 1995-09-20

Similar Documents

Publication Publication Date Title
KR100498646B1 (ko) 경구용 펩티드 약학적 조성물
AU617157B2 (en) Intravaginal delivery of biologically active polypeptides
KR102236462B1 (ko) 에키노칸딘 계열의 화합물에 대한 투여 용법
EP0843558B1 (en) Composition for enhanced uptake of polar drugs from the colon
EP0387352B1 (en) Enteric formulations of physiologically active peptides and proteins
JP2021520391A (ja) 治療用ペプチド及び治療用タンパク質の経粘膜送達のための薬学的組成物
JPH09510182A (ja) カプセル封入されたドラッグデリバリー用透明液
EP2062571B1 (en) Self-emulsifying pharmaceutical composition with enhanced bioavailability
CN102046192A (zh) GnRH相关化合物的组合物及制备方法
WO2002020037A1 (fr) Composition pharmaceutique a administration orale liberee au niveau colique
CN103458873A (zh) 用于口服肽递送的脂肪酸酰化的氨基酸
JPH06509796A (ja) W/oミクロエマルジョン
US20040147578A1 (en) Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
JPH0150686B2 (fi)
JP3181062B2 (ja) 下部消化管崩壊経口製剤
JPH07507565A (ja) 非イオン性表面活性剤を含有する医薬組成物
JP2007535545A (ja) 難吸収性薬剤の経口投与のための製剤
US11185589B2 (en) Formulation for oral delivery of proteins, peptides and small molecules with poor permeability
CA2079157A1 (en) Pharmaceutical compositions
JP2006111558A (ja) 多層構造を有する錠剤状の小腸粘膜付着性経口製剤
JP2005272416A (ja) 消化管粘膜付着性ddsを用いる赤血球増殖因子エリスロポエチン類およびインターフェロン類の経口製剤
WO1995006463A1 (en) Pharmaceutical compositions containing anionic surfactants
CN107205928B (zh) 不稳定或难溶药物的口服投予
EA046567B1 (ru) Композиция для пероральной доставки гидрофильных синтетических или природных молекул со слабой проницаемостью
JPH06199681A (ja) 生理活性ペプチド組成物